HealthDay on MSN1d
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol ConsumptionGlucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...
News Medical on MSN3d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumptionThe impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...
Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...
News Medical on MSN5d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or deathA large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
5don MSN
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will ...
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual fibroblast growth factor 21 ...
At ObesityWeek 2024, researchers presented the latest data on treatment regimens for chronic weight management, including GLP ...
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback